A Regenerative Medicine and Cellular Therapy Manufacturing Company
Longeveron LLC was founded to provide cell therapeutics for unmet medical needs. The company’s lead product, Longeveron Mesenchymal Stem Cells (LMSCs), is currently being evaluated in several Phase 1 – 2b clinical trials under FDA oversight. Indications being explored include Aging Frailty, Alzheimer’s Disease, the Metabolic Syndrome and Hypoplastic Left Heart Syndrome. Longeveron is a private company, and recipient of 5 grant awards, including from the National Institutes of Health, the Alzheimer’s Association, and the Maryland Stem Cell Research Fund. Longeveron also offers state of the art manufacturing capabilities for third parties in its Miami based cGMP facilities.